Eric L Nuermberger Selected Research

Persistent Infection

10/2023	Identification of 2-Aryl-Quinolone Inhibitors of Cytochrome bd and Chemical Validation of Combination Strategies for Respiratory Inhibitors against Mycobacterium tuberculosis.
1/2021	Pharmacodynamic Correlates of Linezolid Activity and Toxicity in Murine Models of Tuberculosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Eric L Nuermberger Research Topics

Disease

64	Tuberculosis (Tuberculoses) 04/2024 - 02/2004
30	Infections 12/2022 - 08/2009
14	Buruli Ulcer 10/2021 - 07/2010
12	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 04/2024 - 08/2009
6	Granuloma 06/2015 - 09/2004
5	Latent Tuberculosis 04/2023 - 12/2009
5	Pulmonary Tuberculosis 01/2022 - 08/2009
4	Body Weight (Weight, Body) 01/2019 - 07/2012
3	Hypoxia (Hypoxemia) 01/2020 - 03/2009
2	Extensively Drug-Resistant Tuberculosis 02/2024 - 11/2021
2	Persistent Infection 10/2023 - 01/2021
2	Acquired Immunodeficiency Syndrome (AIDS) 12/2021 - 06/2020
2	Ulcer 01/2019 - 01/2013
1	Bacteremia 10/2022
1	Wound Infection (Wound Infections) 10/2022
1	Staphylococcal Infections 10/2022
1	Communicable Diseases (Infectious Diseases) 01/2022
1	Bacterial Infections (Bacterial Infection) 12/2020
1	Lung Diseases (Lung Disease) 01/2019
1	Nontuberculous Mycobacterium Infections 01/2019
1	Necrosis 06/2015
1	Hearing Loss (Hearing Impairment) 01/2015
1	Neglected Diseases 01/2014
1	Skin Diseases (Skin Disease) 10/2011
1	Cicatrix (Scar) 03/2011
1	Emerging Communicable Diseases (Emerging Infectious Diseases) 07/2010

Drug/Important Bio-Agent (IBA)

23	Rifampin (Rifampicin)FDA LinkGeneric 01/2022 - 02/2004
21	Isoniazid (Ftivazide)FDA LinkGeneric 04/2024 - 02/2004
20	Pyrazinamide FDA LinkGeneric 01/2022 - 02/2004
17	rifapentine (Priftin)FDA Link 04/2023 - 12/2005
14	pretomanidIBA 02/2024 - 01/2011
14	bedaquiline (R207910)IBA 02/2024 - 09/2011
14	Moxifloxacin (Avelox)FDA Link 01/2022 - 02/2004
13	Anti-Bacterial Agents (Antibiotics)IBA 12/2022 - 04/2011
13	AerosolsIBA 01/2019 - 03/2009
10	Linezolid (Zyvox)FDA Link 02/2024 - 08/2009
10	RifamycinsIBA 01/2022 - 07/2006
6	FluoroquinolonesIBA 01/2022 - 04/2011
5	Oxazolidinones (2 Oxazolidone)IBA 01/2023 - 08/2009
5	Streptomycin (Streptomycin Sulfate)FDA Link 01/2019 - 10/2010
5	Clofazimine (Lamprene)FDA Link 01/2019 - 05/2013
4	DiarylquinolinesIBA 01/2023 - 01/2021
4	VaccinesIBA 01/2020 - 09/2011
4	Ethambutol (Myambutol)FDA LinkGeneric 07/2015 - 08/2012
3	Oxidoreductases (Dehydrogenase)IBA 10/2023 - 01/2019
3	Antitubercular AgentsIBA 10/2023 - 01/2020
3	Rifabutin (Ansamycin)FDA Link 04/2023 - 01/2022
3	LactamsIBA 01/2022 - 01/2019
3	Drug CombinationsIBA 01/2022 - 04/2011
3	telacebecIBA 10/2021 - 01/2019
3	NitroimidazolesIBA 01/2020 - 01/2011
2	9 alpha,11 alpha,15 alpha- trihydroxy- 16- phenoxy- 17,18,19,20- tetranorprosta- 4,5,13- trienoic acid (TPT)IBA 04/2023 - 01/2023
2	TBAJ-876IBA 01/2023 - 11/2021
2	OPC-67683IBA 01/2022 - 01/2020
2	Carbapenems (Carbapenem Antibiotics)IBA 01/2022 - 01/2021
2	Meropenem (Merrem)FDA LinkGeneric 01/2022 - 01/2022
2	Imipenem FDA Link 11/2021 - 01/2019
2	ProdrugsIBA 01/2020 - 03/2015
2	mycolactoneIBA 01/2019 - 01/2013
2	AcidsIBA 01/2014 - 10/2012
2	Biomarkers (Surrogate Marker)IBA 01/2012 - 01/2011
1	contezolidIBA 12/2023
1	duroquinol oxidaseIBA 10/2023
1	CytochromesIBA 10/2023
1	PlacebosIBA 10/2022
1	Lysine-tRNA LigaseIBA 10/2022
1	Clavulanic Acid (Potassium Clavulanate)FDA LinkGeneric 01/2022
1	AcetyltransferasesIBA 12/2021
1	Vitamin K 2 (Vitamin K2)IBA 01/2020
1	Lipoproteins (Lipoprotein)IBA 01/2019
1	meropenem and vaborbactamIBA 01/2019
1	Dihydrotachysterol (AT 10)IBA 01/2019
1	MacrolidesIBA 01/2019
1	Tigecycline (Tygacil)FDA Link 01/2019
1	relebactamIBA 01/2019
1	Clarithromycin (Biaxin)FDA LinkGeneric 01/2019
1	Matrix Metalloproteinases (MMPs)IBA 01/2016
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2016
1	Oxygen (Dioxygen)IBA 03/2015
1	VXc-486IBA 03/2015
1	TBA-354IBA 01/2015
1	Levofloxacin (Levaquin)FDA Link 07/2013
1	beta-LactamsIBA 05/2013
1	trichostatin A (A 300)IBA 11/2012
1	NitrogenIBA 10/2012
1	Fatty Acids (Saturated Fatty Acids)IBA 10/2012
1	CarbonIBA 10/2012
1	pimonidazoleIBA 02/2012
1	7- (7- amino- 7- methyl- 5- azaspiro(2.4)heptan- 5- yl)- 6- fluoro- 1- (2- fluoro- 1- cyclopropyl)- 1,4- dihydro- 8- methoxy- 4- oxo- 3- quinolinecarboxylic acidIBA 04/2011
1	CytokinesIBA 03/2011
1	Glucose (Dextrose)FDA LinkGeneric 11/2009
1	PNU-100480IBA 08/2009

Therapy/Procedure

10	Duration of Therapy 01/2022 - 02/2004
9	Therapeutics 04/2023 - 11/2002
7	Drug Therapy (Chemotherapy) 01/2017 - 02/2004
3	Skin Transplantation (Skin Grafting) 01/2022 - 10/2011
2	Aftercare (After-Treatment) 01/2016 - 01/2013
2	Intramuscular Injections 01/2015 - 10/2010
1	Salvage Therapy 01/2019
1	Combination Drug Therapy (Combination Chemotherapy) 07/2010